Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Apr. 30, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,620 $ 12,360
Short-term investments 21,356 17,327
Receivables 256 47
Prepaid expenses and other current assets 178 466
Total current assets 27,410 30,200
Operating lease right-of-use asset 189 212
Total assets 27,599 30,412
Current liabilities:    
Accounts payable 195 265
Accrued expenses 1,293 1,726
Operating lease liability 49 46
Total current liabilities 1,537 2,037
Operating lease liability, non-current 149 175
Total liabilities 1,686 2,212
Commitments and contingencies (Note 10)
Shareholders’ equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 30,958,665 and 30,913,902 shares issued and outstanding as of April 30, 2023 and October 31, 2022, respectively 310 309
Additional paid-in capital 249,496 247,123
Accumulated deficit (222,995) (218,385)
Total shareholders’ equity 26,811 29,047
Noncontrolling interest (Note 2) (898) (847)
Total equity 25,913 28,200
Total liabilities and equity 27,599 30,412
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, value